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ABSTRACT. Overexpression of the gene coding for α-synuclein has 
been shown to be an inherited cause of Parkinson disease. Our laboratory 
has previously co-expressed the parkin and Pink1 genes to rescue 
α-synuclein-induced phenotypes within a Drosophila model. To further 
investigate the effect of Pink1 in this model, we performed longevity 
and behavioral studies using several drivers to express the α-synuclein 
and Pink1 genes. Our findings showed that overexpression of Pink1 
and overexpression of Pink1 with α-synuclein resulted in an increased 
lifespan when driven with the TH-Gal4 transgene. This increase in 
longevity was accompanied by an increased healthspan, as measured 
by mobility over time, suggesting that this is an example of improved 
functional aging. Our results indicate that, in the dopaminergic cells 
targeted by TH-Gal4, increased expression of α-synuclein and Pink1 
together have a synergistic effect, allowing for enhanced protection and 
increased survival of the organism. 
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INTRODUCTION
Parkinson disease (PD) affects 1-2% of the population over the age of 65 years, where 
age is the largest risk factor for the development and progression of the disease (Lees et al., 
2009). PD is characterized by a progressive loss of dopaminergic neurons in the substan-
tia nigra pars compacta, often including the presence of ubiquitin-positive and α-synuclein-
enriched inclusions, known as Lewy bodies, in the remaining neurons. Several genes have 
been linked to familial forms of PD, including the genes coding for α-synuclein and PTEN- 
induced putative kinase 1 (PINK1). 
Identified as a kinase, PINK1 has been shown to locate to the mitochondria and is 
hypothesized to be involved in their protection (Deas et al., 2009). Mutations in PINK1, and in 
the Drosophila homologue Pink1, show substantial mitochondrial defects in sensitive tissues, 
with the inability to inhibit cytochrome c release under stress conditions (Clark et al., 2006; 
Park et al., 2006; Yang et al., 2006; Exner et al., 2007; Wang et al., 2007). As a protective 
protein, PINK1 may confer protection of the mitochondria through several mechanisms (Deas 
et al., 2009), including an interaction with molecular chaperones to regulate oxidative stress 
responses, activation of the parkin E3 ubiquitin ligase to result in the tagging of toxic proteins, 
such as α-synuclein, for degradation, or through the initiation of fission events to remove dys-
functional mitochondria via mitophagy.
Overexpression of the gene encoding α-synuclein has been shown to be an inherited 
cause of PD, and a transgenic α-synuclein-induced model in Drosophila has been successfully 
used to mimic the degenerative processes seen in PD (Feany and Bender, 2000; Whitworth 
et al., 2006). Previous study in our laboratory has shown the ability of parkin overexpression 
and Pink1 overexpression to rescue an α-synuclein-induced PD-like phenotype in Drosophila 
melanogaster, presumably through the targeting of the α-synuclein protein for degradation 
(Haywood and Staveley, 2004; Todd and Staveley, 2008). To further investigate the effect of 
Pink1 in this model, we performed longevity and behavioral studies using several neuronal 
and ubiquitous drivers to express the α-synuclein and Pink1 transgenes. 
MATERIAL AND METHODS
Dr. M. Feany (Harvard Medical School) generously provided the UAS-α-synuclein 
flies (Feany and Bender, 2000) and Dr. J. Hirsh (University of Virginia) provided the Dopa 
decarboxylase-Gal4 (Ddc-Gal4) flies (Li et al., 2000) and the tyrosine hydroxylase-Gal4 
(TH-Gal4) flies (Friggi-Grelin et al., 2003). The UAS-Pink1 transgenic line was cre-
ated using the GH20931 D. melanogaster Pink1 clone (Todd and Staveley, 2008). The 
UAS-α-synuclein;UAS-Pink1 line was generated using standard techniques. The w1118 flies 
were obtained from Dr. Howard Lipshitz at the Hospital for Sick Children in Toronto. The 
GawBC739-Gal4, GawBV55-Gal4, Elav-Gal4, Arm-Gal4, and UAS-GFP were obtained from the 
Bloomington Drosophila Stock Center at Indiana University. All flies were cultured on stan-
dard cornmeal/yeast/molasses/agar medium at 25°C.
Two hundred adult males of each genotype were collected under gaseous carbon diox-
ide and aged upon standard cornmeal/yeast/molasses/agar medium, at 25°C, in upright standard 
plastic shell vials. Flies were maintained in non-crowded conditions with one to twenty indi-
viduals per vial. Flies were scored for viability every two days and transferred to fresh medium 
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according to an established protocol (Staveley et al., 1990). Forty adult males of each genotype 
were assayed for climbing ability (Todd and Staveley, 2004). Flies were maintained on standard 
cornmeal/yeast/molasses/agar medium at 25°C and were assayed every seven days.
RESULTS
Overexpression of Pink1 increases lifespan when driven with TH-Gal4 (Figure 1A). 
In addition, overexpression of Pink1 with α-synuclein, using the TH-Gal4 driver, results in a 
dramatic increase in lifespan. The results suggested that increases in expression of α-synuclein 
and Pink1 together can have a synergistic effect, allowing for enhanced cellular protection and 
increased survival. When assessing the extension of lifespan observed in Figure 1A, it was nec-
essary to determine if this was accompanied by improved healthspan or functional aging in the 
surviving individuals. D. melanogaster exhibit a strong negative geotactic climbing response, 
allowing for the conduct of mobility assays within the α-synuclein-induced model (Haywood 
and Staveley, 2004; Todd and Staveley, 2008). When we assessed the climbing ability of flies 
expressing Pink1, using the TH-Gal4 driver (Figure 1B), there was a rescue of the characteristic 
α-synuclein-induced phenotype of premature loss of climbing ability. In addition, flies express-
ing Pink1 with α-synuclein using the TH-Gal4 driver had a significant increase in climbing abil-
ity in the surviving flies as compared to other genotypes of the same age. This suggests that the 
increase in longevity was an example of healthy aging, and that the lifespan difference observed 
between Pink1 with α-synuclein and Pink1 expression alone was a synergistic effect.
Figure 1. Effect of Pink1 and α-synuclein expression on longevity (A) and mobility (B) when driven with TH-Gal4. 
Overexpression of Pink1 using the TH-Gal4 driver shows an increase in lifespan (mean = 72 days) as compared 
to controls (mean = 61 ± 1 days), P < 0.0001 (A). Overexpression of Pink1 with α-synuclein using the TH-Gal4 
driver shows a dramatic increase in lifespan (mean = 86 days) as compared to controls (mean = 61 ± 1 days), P < 
0.0001. Overexpression of Pink1 results in a rescue of the α-synuclein-induced premature loss of climbing ability 
when driven with TH-Gal4 (B). Overexpression of Pink1 with α-synuclein, using TH-Gal4, shows significantly 
increased climbing ability above that of controls (non-linear curve fit comparison, CI = 95%). Survival curves were 
compared using the log-rank test. Genotypes expressed include w1118 (Control Ø); UAS-GFP/+ (Control G); UAS-
α-synuclein/+ (α-syn); UAS-Pink1/+ (Pink1), and UAS-α-synuclein/+;UAS-Pink1/+ (α-syn + Pink1). Error bars 
indicate standard error of the mean.
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To investigate the effect of α-synuclein and Pink1 expression in other cell populations, 
longevity studies were performed using a variety of established constitutive drivers (Figure 
2). The significant increases in lifespan shown with TH-Gal4 (Figure 1A) were not observed 
when using other drivers, including neuronal (Elav-Gal4, GawBC739-Gal4, GawBV55-Gal4) and 
ubiquitous (Arm-Gal4) drivers. This suggests that the increases in longevity were dependent 
on expression within the dopaminergic neurons targeted by TH-Gal4.
Figure 2. Effect of Pink1 and α-synuclein expression on longevity when driven with GawBC739-Gal4 (A), GawBV55-
Gal4 (B), Elav-Gal4 (C), and arm-Gal4 (D). Survival curves were compared using the log-rank test. Genotypes 
expressed include w1118 (Control Ø); UAS-GFP/+ (Control G); UAS-α-synuclein/+ (α-syn); UAS-Pink1/+ (Pink1), 
and UAS-α-synuclein/+;UAS-Pink1/+ (α-syn + Pink1). Error bars indicate standard error of the mean.
DISCUSSION
Our findings show that expression of Pink1 with α-synuclein has a synergistic effect when 
driven with the TH-Gal4 transgene, leading to increased longevity in Drosophila. Healthspan, as 
measured by climbing ability over time, is also enhanced, suggesting an improvement of functional 
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aging in these flies, opposed to longevity alone. This protective effect is of interest, as α-synuclein 
is involved in a central pathogenic mechanism for Parkinson disease and has been linked to vari-
ous aspects of mitochondrial dysfunction (Schapira and Gegg, 2011). Previous studies indicate 
that the accumulation of α-synuclein in the mitochondria of mammalian dopaminergic neurons 
leads to reduced mitochondrial complex I activity and increased production of reactive oxygen 
species (ROS) (Devi et al., 2008; Liu et al., 2009). It is important to note that ROS also act as 
signaling molecules, and can be involved in a number of pro-survival pathways, including regula-
tion of autophagy (Scherz-Shouval and Elazar, 2007; Weber and Reichert, 2010). In this respect, 
α-synuclein may be involved in the turnover of mitochondria by autophagy, or mitophagy, acting 
in unison with Pink1 in a pro-survival role via the removal of defective mitochondria.
The increases in lifespan shown with TH-Gal4 have not been observed when using 
other drivers, including neuronal (Elav-Gal4, GawBC739-Gal4, GawBV55-Gal4) and ubiquitous 
(Arm-Gal4) drivers. Within the cell, tyrosine hydroxylase enzyme catalyzes the conversion of 
l-tyrosine to l-dopa, which is the initial and rate-limiting step in the biosynthesis of catechol-
amines such as dopamine. These dopaminergic neurons are particularly sensitive, perhaps ex-
acerbated by the metabolic stress created by sustained Ca2+ entry during signaling (Surmeier et 
al., 2010). Pink1 may have a more pronounced protective effect in this particular cell type, as 
Pink1 acts through a general protective role but can also directly regulate calcium flux through 
the mitochondria (Deas et al., 2009). Interestingly, previous study in our laboratory expressing 
α-synuclein and Pink1 using Ddc-Gal4 (Todd and Staveley, 2008) has not shown the synergistic 
effect seen in this study, using TH-Gal4. Dopa decarboxylase catalyzes the last step of dopamine 
synthesis, l-dopa to dopamine, and the last step of serotonin synthesis, l-tryptophan to serotonin. 
The discrepancies between results seen when using the TH-Gal4 driver and the Ddc-Gal4 driver 
are likely due to differing coverage of the dopaminergic neurons. There is growing evidence that 
although all dopaminergic neuron clusters in the fly brain seem to be targeted by the TH-Gal4 
driver, they are not covered equally, and that Ddc-Gal4 likely does not target all dopaminergic 
neuronal clusters (Yarali and Gerber, 2010). This incomplete overlap of dopaminergic neurons 
targeted by the TH-Gal4 and Ddc-Gal4 transgenes may indicate that there is a particular dopa-
minergic cell cluster responsible for the increased lifespan observed in this study. It will be im-
portant for future studies to examine the differences between the TH-Gal4 and Ddc-Gal4 drivers 
with respect to aging and functional longevity.
Our results suggest that increases in α-synuclein and Pink1 together may have a syn-
ergistic effect, allowing for enhanced protection and increased functional longevity in Dro-
sophila. This may be a result of the upregulation of pro-survival mechanisms via Pink1, in 
response to an increase in ROS signaling due to α-synuclein overexpression. The restriction of 
these results to TH-Gal4-expressing cells likely reflects the existence of a dopaminergic cell 
cluster that is particularly sensitive to changes in Pink1 and α-synuclein expression. Moreover, 
the results indicate the need for future examination of this particular cell population, where 
findings may shift therapeutic efforts towards a particular dopaminergic cluster.
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